EU lifts neuropsychiatric warning for Pfizer’s Champix
European regulators have removed the black triangle warning from the label of Pfizer’s smoking cessation drug Champix, on the back of data from a post-marketing surveillance study backing its neuropsychiatric safety.
Read More
